Meet NovaMatrix® at 2022 TERMIS-AM Conference, Toronto
Catalyzing biotechnology, accelerating innovation
At NovaMatrix®, we leverage IFF Pharma Solutions unrivaled polymer design capabilities and global manufacturing footprint to bring ultrapure biopolymers and custom solutions to the biopharmaceutical and medical device industries.
IFF NovaMatrix® invests in polymer science to advance medical innovations. For example, our NOVATACH™ peptide-coupled alginates promote interactions between cells and alginate-based scaffolds, opening up plenty of development opportunities in cell immobilization, 3D bio-printing, tissue design, and more!
Our NovaMatrix® facility near Oslo, Norway is cGMP, ISO9001 and ISO13485 qualified to ensure quality, reliability, and safety. We hold an API manufacturing license from the Norwegian Medicines Agency and our ultrapure sodium alginate is described in a Drug Master File with the US Food & Drug administration.
July 10-13, 2022
Booth 26
2022 TERMIS-AM Conference Toronto, Canada
Join us at 2022 TERMIS-AM Conference
Discover how we are leading the conversation as a producer of ultrapure biopolymers for applications such as drug delivery, tissue engineering, cell encapsulation, and medical devices.
Our IFF NovaMatrix® experts are here to talk about ‘Catalyzing the Future of Biotechnology’.
Please fill out the form to connect with us at Termis-AM Conference in Toronto or to schedule a virtual meeting.